Pharmaceuticals

Europe Biosimilar Drug Market Report 2017

  • QYR905269
  • 122 Pages
  • February 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Biosimilar Drug

Revenue, means the sales value of Biosimilar Drug

This report studies sales (consumption) of Biosimilar Drug in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

CP Guojian Pharma

Biotech Pharma

Celgen Pharma

Henlius

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Biosimilar Drug in these countries, from 2011 to 2021 (forecast), like

Germany

France

UK

Russia

Italy

Spain

Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

Injection

Tablets

Others

Split by application, this report focuses on sales, market share and growth rate of Biosimilar Drug in each application, can be divided into

Ankylosing Spondylitis

Tumor

Rheumatoid Arthrtis

Cardiovascular

Table of Contents

Europe Biosimilar Drug Market Report 2017

1 Biosimilar Drug Overview

1.1 Product Overview and Scope of Biosimilar Drug

1.2 Classification of Biosimilar Drug

1.2.1 Injection

1.2.2 Tablets

1.2.3 Others

1.3 Application of Biosimilar Drug

1.3.1 Ankylosing Spondylitis

1.3.2 Tumor

1.3.3 Rheumatoid Arthrtis

1.3.4 Cardiovascular

1.4 Biosimilar Drug Market by Countries

1.4.1 Germany Status and Prospect (2012-2022)

1.4.2 France Status and Prospect (2012-2022)

1.4.3 UK Status and Prospect (2012-2022)

1.4.4 Russia Status and Prospect (2012-2022)

1.4.5 Italy Status and Prospect (2012-2022)

1.4.6 Spain Status and Prospect (2012-2022)

1.4.7 Benelux Status and Prospect (2012-2022)

1.5 Europe Market Size (Value and Volume) of Biosimilar Drug (2012-2022)

1.5.1 Europe Biosimilar Drug Sales and Growth Rate (2012-2022)

1.5.2 Europe Biosimilar Drug Revenue and Growth Rate (2012-2022)

2 Europe Biosimilar Drug by Manufacturers, Type and Application

2.1 Europe Biosimilar Drug Market Competition by Manufacturers

2.1.1 Europe Biosimilar Drug Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Biosimilar Drug Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Biosimilar Drug (Volume and Value) by Type

2.2.1 Europe Biosimilar Drug Sales and Market Share by Type (2012-2017)

2.2.2 Europe Biosimilar Drug Revenue and Market Share by Type (2012-2017)

2.3 Europe Biosimilar Drug (Volume and Value) by Countries

2.3.1 Europe Biosimilar Drug Sales and Market Share by Countries (2012-2017)

2.3.2 Europe Biosimilar Drug Revenue and Market Share by Countries (2012-2017)

2.4 Europe Biosimilar Drug (Volume) by Application

3 Germany Biosimilar Drug (Volume, Value and Sales Price)

3.1 Germany Biosimilar Drug Sales and Value (2012-2017)

3.1.1 Germany Biosimilar Drug Sales and Growth Rate (2012-2017)

3.1.2 Germany Biosimilar Drug Revenue and Growth Rate (2012-2017)

3.1.3 Germany Biosimilar Drug Sales Price Trend (2012-2017)

3.2 Germany Biosimilar Drug Sales and Market Share by Manufacturers

3.3 Germany Biosimilar Drug Sales and Market Share by Type

3.4 Germany Biosimilar Drug Sales and Market Share by Application

4 France Biosimilar Drug (Volume, Value and Sales Price)

4.1 France Biosimilar Drug Sales and Value (2012-2017)

4.1.1 France Biosimilar Drug Sales and Growth Rate (2012-2017)

4.1.2 France Biosimilar Drug Revenue and Growth Rate (2012-2017)

4.1.4 France Biosimilar Drug Sales Price Trend (2012-2017)

4.2 France Biosimilar Drug Sales and Market Share by Manufacturers

4.3 France Biosimilar Drug Sales and Market Share by Type

4.4 France Biosimilar Drug Sales and Market Share by Application

5 UK Biosimilar Drug (Volume, Value and Sales Price)

5.1 UK Biosimilar Drug Sales and Value (2012-2017)

5.1.1 UK Biosimilar Drug Sales and Growth Rate (2012-2017)

5.1.2 UK Biosimilar Drug Revenue and Growth Rate (2012-2017)

5.1.5 UK Biosimilar Drug Sales Price Trend (2012-2017)

5.2 UK Biosimilar Drug Sales and Market Share by Manufacturers

5.3 UK Biosimilar Drug Sales and Market Share by Type

5.4 UK Biosimilar Drug Sales and Market Share by Application

6 Russia Biosimilar Drug (Volume, Value and Sales Price)

6.1 Russia Biosimilar Drug Sales and Value (2012-2017)

6.1.1 Russia Biosimilar Drug Sales and Growth Rate (2012-2017)

6.1.2 Russia Biosimilar Drug Revenue and Growth Rate (2012-2017)

6.1.6 Russia Biosimilar Drug Sales Price Trend (2012-2017)

6.2 Russia Biosimilar Drug Sales and Market Share by Manufacturers

6.3 Russia Biosimilar Drug Sales and Market Share by Type

6.4 Russia Biosimilar Drug Sales and Market Share by Application

7 Italy Biosimilar Drug (Volume, Value and Sales Price)

7.1 Italy Biosimilar Drug Sales and Value (2012-2017)

7.1.1 Italy Biosimilar Drug Sales and Growth Rate (2012-2017)

7.1.2 Italy Biosimilar Drug Revenue and Growth Rate (2012-2017)

7.1.7 Italy Biosimilar Drug Sales Price Trend (2012-2017)

7.2 Italy Biosimilar Drug Sales and Market Share by Manufacturers

7.3 Italy Biosimilar Drug Sales and Market Share by Type

7.4 Italy Biosimilar Drug Sales and Market Share by Application

8 Spain Biosimilar Drug (Volume, Value and Sales Price)

8.1 Spain Biosimilar Drug Sales and Value (2012-2017)

8.1.1 Spain Biosimilar Drug Sales and Growth Rate (2012-2017)

8.1.2 Spain Biosimilar Drug Revenue and Growth Rate (2012-2017)

8.1.8 Spain Biosimilar Drug Sales Price Trend (2012-2017)

8.2 Spain Biosimilar Drug Sales and Market Share by Manufacturers

8.3 Spain Biosimilar Drug Sales and Market Share by Type

8.4 Spain Biosimilar Drug Sales and Market Share by Application

9 Benelux Biosimilar Drug (Volume, Value and Sales Price)

9.1 Benelux Biosimilar Drug Sales and Value (2012-2017)

9.1.1 Benelux Biosimilar Drug Sales and Growth Rate (2012-2017)

9.1.2 Benelux Biosimilar Drug Revenue and Growth Rate (2012-2017)

9.1.9 Benelux Biosimilar Drug Sales Price Trend (2012-2017)

9.2 Benelux Biosimilar Drug Sales and Market Share by Manufacturers

9.3 Benelux Biosimilar Drug Sales and Market Share by Type

9.4 Benelux Biosimilar Drug Sales and Market Share by Application

10 Europe Biosimilar Drug Manufacturers Analysis

10.1 CP Guojian Pharma

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Biosimilar Drug Product Type, Application and Specification

10.1.2.1 Product A

10.1.2.2 Product B

10.1.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)

10.1.4 Main Business/Business Overview

10.2 Biotech Pharma

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Biosimilar Drug Product Type, Application and Specification

10.2.2.1 Product A

10.2.2.2 Product B

10.2.3 Biotech Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)

10.2.4 Main Business/Business Overview

10.3 Celgen Pharma

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Biosimilar Drug Product Type, Application and Specification

10.3.2.1 Product A

10.3.2.2 Product B

10.3.3 Celgen Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)

10.3.4 Main Business/Business Overview

10.4 Henlius

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Biosimilar Drug Product Type, Application and Specification

10.4.2.1 Product A

10.4.2.2 Product B

10.4.3 Henlius Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)

10.4.4 Main Business/Business Overview

11 Biosimilar Drug Manufacturing Cost Analysis

11.1 Biosimilar Drug Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Biosimilar Drug

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Biosimilar Drug Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe Biosimilar Drug Market Forecast (2017-2022)

14.1 Germany Biosimilar Drug Sales Forecast (2017-2022)

14.2 France Biosimilar Drug Sales Forecast (2017-2022)

14.3 UK Biosimilar Drug Sales Forecast (2017-2022)

14.4 Russia Biosimilar Drug Sales Forecast (2017-2022)

14.5 Italy Biosimilar Drug Sales Forecast (2017-2022)

14.6 Spain Biosimilar Drug Sales Forecast (2017-2022)

14.7 Benelux Biosimilar Drug Sales Forecast (2017-2022)

14.8 Europe Biosimilar Drug Sales Forecast by Type (2017-2022)

14.9 Europe Biosimilar Drug Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of Biosimilar Drug

Table Classification of Biosimilar Drug

Figure Europe Sales Market Share of Biosimilar Drug by Type in 2015

Figure Injection Picture

Figure Tablets Picture

Figure Others Picture

Table Application of Biosimilar Drug

Figure Europe Sales Market Share of Biosimilar Drug by Application in 2015

Figure Ankylosing Spondylitis Examples

Figure Tumor Examples

Figure Rheumatoid Arthrtis Examples

Figure Cardiovascular Examples

Figure Germany Biosimilar Drug Revenue and Growth Rate (2012-2022)

Figure France Biosimilar Drug Revenue and Growth Rate (2012-2022)

Figure UK Biosimilar Drug Revenue and Growth Rate (2012-2022)

Figure Russia Biosimilar Drug Revenue and Growth Rate (2012-2022)

Figure Italy Biosimilar Drug Revenue and Growth Rate (2012-2022)

Figure Spain Biosimilar Drug Revenue and Growth Rate (2012-2022)

Figure Benelux Biosimilar Drug Revenue and Growth Rate (2012-2022)

Figure Europe Biosimilar Drug Sales and Growth Rate (2012-2022)

Figure Europe Biosimilar Drug Revenue and Growth Rate (2012-2022)

Table Europe Biosimilar Drug Sales of Key Manufacturers (2015 and 2016)

Table Europe Biosimilar Drug Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Biosimilar Drug Sales Share by Manufacturers

Figure 2016 Biosimilar Drug Sales Share by Manufacturers

Table Europe Biosimilar Drug Revenue by Manufacturers (2015 and 2016)

Table Europe Biosimilar Drug Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Biosimilar Drug Revenue Share by Manufacturers

Table 2016 Europe Biosimilar Drug Revenue Share by Manufacturers

Table Europe Biosimilar Drug Sales and Market Share by Type (2012-2017)

Table Europe Biosimilar Drug Sales Share by Type (2012-2017)

Figure Sales Market Share of Biosimilar Drug by Type (2012-2017)

Figure Europe Biosimilar Drug Sales Growth Rate by Type (2012-2017)

Table Europe Biosimilar Drug Revenue and Market Share by Type (2012-2017)

Table Europe Biosimilar Drug Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Biosimilar Drug by Type (2012-2017)

Figure Europe Biosimilar Drug Revenue Growth Rate by Type (2012-2017)

Table Europe Biosimilar Drug Sales and Market Share by Countries (2012-2017)

Table Europe Biosimilar Drug Sales Share by Countries (2012-2017)

Figure Sales Market Share of Biosimilar Drug by Countries (2012-2017)

Table Europe Biosimilar Drug Revenue and Market Share by Countries (2012-2017)

Table Europe Biosimilar Drug Revenue Share by Countries (2012-2017)

Figure Revenue Market Share of Biosimilar Drug by Countries (2012-2017)

Table Europe Biosimilar Drug Sales and Market Share by Application (2012-2017)

Table Europe Biosimilar Drug Sales Share by Application (2012-2017)

Figure Sales Market Share of Biosimilar Drug by Application (2012-2017)

Figure Germany Biosimilar Drug Sales and Growth Rate (2012-2017)

Figure Germany Biosimilar Drug Revenue and Growth Rate (2012-2017)

Figure Germany Biosimilar Drug Sales Price Trend (2012-2017)

Table Germany Biosimilar Drug Sales by Manufacturers (2015 and 2016)

Table Germany Biosimilar Drug Market Share by Manufacturers (2015 and 2016)

Table Germany Biosimilar Drug Sales by Type (2015 and 2016)

Table Germany Biosimilar Drug Market Share by Type (2015 and 2016)

Table Germany Biosimilar Drug Sales by Application (2015 and 2016)

Table Germany Biosimilar Drug Market Share by Application (2015 and 2016)

Figure France Biosimilar Drug Sales and Growth Rate (2012-2017)

Figure France Biosimilar Drug Revenue and Growth Rate (2012-2017)

Figure France Biosimilar Drug Sales Price Trend (2012-2017)

Table France Biosimilar Drug Sales by Manufacturers (2015 and 2016)

Table France Biosimilar Drug Market Share by Manufacturers (2015 and 2016)

Table France Biosimilar Drug Sales by Type (2015 and 2016)

Table France Biosimilar Drug Market Share by Type (2015 and 2016)

Table France Biosimilar Drug Sales by Application (2015 and 2016)

Table France Biosimilar Drug Market Share by Application (2015 and 2016)

Figure UK Biosimilar Drug Sales and Growth Rate (2012-2017)

Figure UK Biosimilar Drug Revenue and Growth Rate (2012-2017)

Figure UK Biosimilar Drug Sales Price Trend (2012-2017)

Table UK Biosimilar Drug Sales by Manufacturers (2015 and 2016)

Table UK Biosimilar Drug Market Share by Manufacturers (2015 and 2016)

Table UK Biosimilar Drug Sales by Type (2015 and 2016)

Table UK Biosimilar Drug Market Share by Type (2015 and 2016)

Table UK Biosimilar Drug Sales by Application (2015 and 2016)

Table UK Biosimilar Drug Market Share by Application (2015 and 2016)

Figure Russia Biosimilar Drug Sales and Growth Rate (2012-2017)

Figure Russia Biosimilar Drug Revenue and Growth Rate (2012-2017)

Figure Russia Biosimilar Drug Sales Price Trend (2012-2017)

Table Russia Biosimilar Drug Sales by Manufacturers (2015 and 2016)

Table Russia Biosimilar Drug Market Share by Manufacturers (2015 and 2016)

Table Russia Biosimilar Drug Sales by Type (2015 and 2016)

Table Russia Biosimilar Drug Market Share by Type (2015 and 2016)

Table Russia Biosimilar Drug Sales by Application (2015 and 2016)

Table Russia Biosimilar Drug Market Share by Application (2015 and 2016)

Figure Italy Biosimilar Drug Sales and Growth Rate (2012-2017)

Figure Italy Biosimilar Drug Revenue and Growth Rate (2012-2017)

Figure Italy Biosimilar Drug Sales Price Trend (2012-2017)

Table Italy Biosimilar Drug Sales by Manufacturers (2015 and 2016)

Table Italy Biosimilar Drug Market Share by Manufacturers (2015 and 2016)

Table Italy Biosimilar Drug Sales by Type (2015 and 2016)

Table Italy Biosimilar Drug Market Share by Type (2015 and 2016)

Table Italy Biosimilar Drug Sales by Application (2015 and 2016)

Table Italy Biosimilar Drug Market Share by Application (2015 and 2016)

Figure Spain Biosimilar Drug Sales and Growth Rate (2012-2017)

Figure Spain Biosimilar Drug Revenue and Growth Rate (2012-2017)

Figure Spain Biosimilar Drug Sales Price Trend (2012-2017)

Table Spain Biosimilar Drug Sales by Manufacturers (2015 and 2016)

Table Spain Biosimilar Drug Market Share by Manufacturers (2015 and 2016)

Table Spain Biosimilar Drug Sales by Type (2015 and 2016)

Table Spain Biosimilar Drug Market Share by Type (2015 and 2016)

Table Spain Biosimilar Drug Sales by Application (2015 and 2016)

Table Spain Biosimilar Drug Market Share by Application (2015 and 2016)

Figure Benelux Biosimilar Drug Sales and Growth Rate (2012-2017)

Figure Benelux Biosimilar Drug Revenue and Growth Rate (2012-2017)

Figure Benelux Biosimilar Drug Sales Price Trend (2012-2017)

Table Benelux Biosimilar Drug Sales by Manufacturers (2015 and 2016)

Table Benelux Biosimilar Drug Market Share by Manufacturers (2015 and 2016)

Table Benelux Biosimilar Drug Sales by Type (2015 and 2016)

Table Benelux Biosimilar Drug Market Share by Type (2015 and 2016)

Table Benelux Biosimilar Drug Sales by Application (2015 and 2016)

Table Benelux Biosimilar Drug Market Share by Application (2015 and 2016)

Table Biosimilar Drug Basic Information List

Table CP Guojian Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Figure CP Guojian Pharma Biosimilar Drug Sales Market Share (2012-2017)

Table Biotech Pharma Basic Information List

Table Biotech Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Table Biotech Pharma Biosimilar Drug Sales Market Share (2012-2017)

Table Celgen Pharma Basic Information List

Table Celgen Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Table Celgen Pharma Biosimilar Drug Sales Market Share (2012-2017)

Table Henlius Basic Information List

Table Henlius Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Table Henlius Biosimilar Drug Sales Market Share (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Biosimilar Drug

Figure Manufacturing Process Analysis of Biosimilar Drug

Figure Biosimilar Drug Industrial Chain Analysis

Table Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2015

Table Major Buyers of Biosimilar Drug

Table Distributors/Traders List

Figure Germany Biosimilar Drug Sales and Growth Rate Forecast (2017-2022)

Figure Germany Biosimilar Drug Revenue and Growth Rate Forecast (2017-2022)

Figure France Biosimilar Drug Sales and Growth Rate Forecast (2017-2022)

Figure France Biosimilar Drug Revenue and Growth Rate Forecast (2017-2022)

Figure UK Biosimilar Drug Sales and Growth Rate Forecast (2017-2022)

Figure UK Biosimilar Drug Revenue and Growth Rate Forecast (2017-2022)

Figure Russia Biosimilar Drug Sales and Growth Rate Forecast (2017-2022)

Figure Russia Biosimilar Drug Revenue and Growth Rate Forecast (2017-2022)

Figure Italy Biosimilar Drug Sales and Growth Rate Forecast (2017-2022)

Figure Italy Biosimilar Drug Revenue and Growth Rate Forecast (2017-2022)

Figure Spain Biosimilar Drug Sales and Growth Rate Forecast (2017-2022)

Figure Spain Biosimilar Drug Revenue and Growth Rate Forecast (2017-2022)

Figure Benelux Biosimilar Drug Sales and Growth Rate Forecast (2017-2022)

Figure Benelux Biosimilar Drug Revenue and Growth Rate Forecast (2017-2022)

Table Europe Biosimilar Drug Sales Forecast by Type (2017-2022)

Table Europe Biosimilar Drug Sales Forecast by Application (2017-2022)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370